Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06296355 · ClinicalTrials.gov registry record · NA
Impacts of Warning Labels on Ultra-Processed Foods
A NA study, sponsored by University of North Carolina, Chapel Hill.
- Completed
- Registry status
- NA
- Development phase
- 4,000
- Enrollment target
NCT06296355: Completed NA study, sponsored by University of North Carolina, Chapel Hill.
NCT06296355 is a NA study that has completed, run by University of North Carolina, Chapel Hill. The registered enrollment target is 4,000 participants, above the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (185% higher). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT06296355, a NA study, has completed, sponsored by University of North Carolina, Chapel Hill.
- COMPLETED
- Registry status
- NA
- Development phase
- 4,000 participants
- Enrollment target
Study Summary
Purpose: The overall purpose of this study is to identify the impacts of an ultra-processed (UPF) health warning label and UPF identify warning label compared to a control label (i.e., a barcode). Participants: \~4,000 US Latino adults of parental age (18-55 years), approximately 50% of whom will have limited English proficiency, recruited from a Latino-focused panel company. Procedures: Participants will be randomly assigned to view food products with one of three label types: health warning labels, identity labels, or barcode control labels. Participants will be asked a series of questions about the products and the label they were assigned.
Primary Outcome
Correct identification of a product as ultra-processed. Measured with the question, "Do you think this product is ultra-processed?" Response options are Yes, No, and I'm not sure.
Interventions
- BEHAVIORAL Health Warning Label
- BEHAVIORAL Identity Warning Label
- OTHER Barcode Label
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 4,000 participants |
| Start Date | 2024-08-09 |
| Est. Completion | 2024-09-11 |
| Phase | NA |
What the finished NCT06296355 record still lists
NCT06296355 is an interventional study that assigns participants to a tested intervention. Its 4,000 participants enrollment target places it among the larger protocols in the corpus, above the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (185% higher).
The record links to 0 conditions, and to 3 interventions - of which Health Warning Label is the first listed.
NCT06296355 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT06296355 about?
NCT06296355 is a clinical study titled "Impacts of Warning Labels on Ultra-Processed Foods". Purpose: The overall purpose of this study is to identify the impacts of an ultra-processed (UPF) health warning label and UPF identify warning label compared to a control label (i.e., a barcode). Participants: \~4,000 US Latino adults of parental age (18-55 years), approximately 50% of whom will h...
What is the current status of trial NCT06296355?
This trial is currently completed. It is a NA study. The enrollment target is 4,000 participants. The study started on 2024-08-09. Estimated completion is 2024-09-11.
What interventions are being tested in trial NCT06296355?
The interventions under investigation include: Health Warning Label (BEHAVIORAL), Identity Warning Label (BEHAVIORAL), Barcode Label (OTHER).
Who is sponsoring clinical trial NCT06296355?
This trial is sponsored by University of North Carolina, Chapel Hill, which has 1,109 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT06296355's enrollment target sits among peer trials
4,000 32nd of 2000 higher than 1,965 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00227253 · 4,000 participants
Chromosome 18 Clinical Research Center
- NCT00811148 · 4,000 participants
Florida Center for Brain Tumor Research
- NCT00897117 · 4,000 participants
Collecting and Analyzing Tissue Samples From Patients Undergoing Surgery for Non-Small Cell Lung Cancer
- NCT00899301 · 4,000 participants
Collecting and Storing Tissue Samples From Women With or Without Breast Cancer
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI